格隆汇2月12日丨瑞普生物(300119.SZ)公布，为推进公司核心战略落地，拓展重点领域业务边界与行业 影响力，充分借助专业机构的资本与资源优势，瑞普生物股份有限公司于2026年2月12日与海通并购 （上海）私募基金管理有限公司（简称"海通并购资本"）、海通开元投资有限公司（简称"海通开元投 资"）、高邮市产业引导基金（有限合伙）（简称"高邮产业引导基金"）及关联方天津瑞晟私募基金管 理有限公司（简称"瑞晟私募"）签署《江苏国泰海通瑞普并购产业基金合伙企业（有限合伙）之合伙协 议》，拟共同出资设立江苏国泰海通瑞普并购产业基金合伙企业（有限合伙）（暂定名，以市场监督管 理机关核准的名称为准，简称"合伙企业"）。该合伙企业将聚焦动物保健、合成生物、宠物、生物医药 等重点领域开展产业投资。合伙企业认缴出资总额为人民币10亿元，其中，公司作为有限合伙人以自有 资金及自筹资金出资人民币2.95亿元，占合伙企业认缴出资总额的29.50%。 ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.86% to 27,032.54 points, the Hang Seng Tech Index down by 1.65% to 5,408.98 points, and the National Enterprises Index decreasing by 1.00% to 9,175.18 points [1] - The Hang Seng Index opened lower at 27,210.56 points, fluctuated downwards, and closed down by 233.84 points, with a total trading volume exceeding 238.7 billion HKD [1] - The net inflow for the southbound trading (Hong Kong Stock Connect) was over 4.5 billion HKD [1] Sector Performance - Most sectors saw declines, with notable exceptions in metals, chips, high-speed rail infrastructure, and wind power, which experienced gains [1] - Sectors such as oil and gas, banking, brokerage, and coal showed mixed performance, while new consumption, gold, commercial aerospace, biomedicine, new energy vehicles, technology, and real estate mostly declined [1] Individual Stock Movements - Xiaomi Group decreased by 1.56%, while Zijin Mining increased by 3.45% [1] - SenseTime rose by 6.77%, and Ctrip Group fell by 3.90% [1] - WuXi Biologics dropped by 0.14%, Pop Mart fell by 1.10%, and SMIC decreased by 0.29% [1] - Notable gainers included Zhizhen Technology with a rise of 28.68%, and Longi Green Energy up by 5.56% [1] - China Construction Bank fell by 0.86%, while CATL increased by 4.14%, and Dongfang Electric surged by 12.38% [1] - Yao Cai Securities Financial dropped by 4.15%, and China Petroleum gained 0.85% [1] Top Traded Stocks - Tencent Holdings fell by 2.28% with a trading volume exceeding 21.2 billion HKD [2] - Alibaba decreased by 0.94% with a trading volume over 8.9 billion HKD [2] - Meituan dropped by 4.50% with a trading volume of 7.7 billion HKD [2]

截至2026年2月12日收盘，诺唯赞(688105)报20.90元，当日下跌0.76%，成交额1572万元；近5日累计跌 幅0.43%，振幅收窄至1.09%。资金流向显示，2月11日主力资金净流入7.11万元；2月12日主力净流入 81.05万元，散户资金呈净流出态势。 以上内容基于公开资料整理，不构成投资建议。 经济观察网2026年2月6日，诺唯赞参与阿尔茨海默病血浆生物标志物学术会议，助力西北多中心研究深 化落地，推动AD早期诊断临床转化。同日，诺唯赞与泰康医疗达成战略合作，共同构建阿尔茨海默病 防治新生态，聚焦血液生物标志物检测的基层应用。2026年2月11日，公司董事会审议通过2026年度日 常关联交易预计金额1490万元，涉及销售产品和技术服务等。 股票近期走势 ...

中新社合肥2月12日电 (记者赵强)安徽省商务厅副厅长、省自贸办常务副主任后其洁12日披露，中国(安 徽)自由贸易试验区(下称"安徽自贸试验区")支持符合条件的港澳台医生取得医师资格证书后，在该自贸 试验区短期执业。 此次《试点举措》凸显四大特色，突出全链条改革、制度型开放、市场化导向和高质量发展。其中，在 制度型开放方面，除支持港澳台医生短期执业外，还吸引境外高端医药人才入驻，汇聚全球创新资源。 市场化导向下，针对企业诉求推出"双白名单"等制度，优化监管服务。 后其洁表示，安徽将跟踪政策落地，优化相关举措并复制推广经验，同时健全风险管控机制，严守伦 理、生物安全等底线，确保生物医药创新发展行稳致远。(完) （文章来源：中国新闻网） 当天，《关于支持中国(安徽)自由贸易试验区合肥片区生物医药产业链关键环节集成创新试点举措》(下 称《试点举措》)政策解读新闻发布会在合肥举行。 后其洁在会上介绍，《试点举措》围绕支持合肥片区生物医药产业研发、生产、审评、应用等关键环 节，从4方面提出20项具体举措。这是安徽自贸试验区设立以来首个产业链集成创新措施。 据悉，《试点举措》构建起"研发—生产—审评—应用"全链条支持体系 ...

美国西北大学科学家开发出迄今最先进的人类脊髓损伤类器官模型，能精准模拟脊髓损伤的关键病理特 征，并为测试新型再生疗法提供了高效平台。该研究首次利用实验室培养的人类脊髓类器官（即由干细 胞衍生的微型器官结构）模拟了不同类型脊髓损伤，并验证了具有潜力的新型"跳动分子"治疗策略。相 关成果发表于新一期《自然·生物医学工程》。 分子运动能力是该疗法生效的关键因素。在对照实验中，运动性较弱的分子未能引发类似的再生效果。 这一发现为理解该疗法作用机制提供了重要依据。 该类器官模型能够重现损伤后的典型变化，包括细胞死亡、炎症反应以及胶质瘢痕形成。胶质瘢痕是由 密集疤痕组织构成的物理化学屏障，长期以来被认为是阻碍神经再生的主要障碍。 （文章来源：科技日报） 团队重点测试了一种被称为"跳动分子"的新型疗法。该疗法在早前动物实验中已显示出能促进组织修复 并逆转瘫痪的效果。在本次类器官实验中，受损组织在治疗后表现出显著的神经元轴突生长，同时胶质 瘢痕样组织也明显减少。这些结果进一步支持该疗法具有转化为临床应用的潜力，其已获得美国食品药 品监督管理局的认证，有望为脊髓损伤患者提供新的治疗选择。 该脊髓类器官直径可达数毫米，具备较高的 ...

股价与板块表现方面，截至2月12日，新芝生物5日累计跌幅0.74%，报14.70元，表现弱于生物医药板块 同期0.71%的涨幅。 经济观察网新芝生物(920685)近期热点集中于资金面波动和板块情绪影响。融资交易活跃度变化显示， 2月10日获融资买入55.56万元，融资余额1328.35万元，处于近一年90%分位高位；对比2月5日融资净卖 出72.3万元，显示短期杠杆资金情绪由谨慎转向小幅回暖。股价与板块表现方面，截至2月12日，新芝 生物5日累计跌幅0.74%，报14.70元，表现弱于生物医药板块同期0.71%的涨幅。 以上内容基于公开资料整理，不构成投资建议。 资金面情况 股票近期走势 融资交易活跃度变化显示，2月10日获融资买入55.56万元，融资余额1328.35万元，处于近一年90%分位 高位；对比2月5日融资净卖出72.3万元，显示短期杠杆资金情绪由谨慎转向小幅回暖。 ...

Group 1 - The core viewpoint of the news is that Yiqiao Shenzhou (301047) is participating in the 15th Cell Biology Industry Conference, which focuses on cell therapy and regenerative medicine, scheduled for March 5-6, 2026, in Chengdu [1] - The number of shareholders in Yiqiao Shenzhou increased by 2.44% as of February 9, 2026, indicating a change in investor interest [1] Group 2 - Over the past 7 days (February 6 to 11, 2026), Yiqiao Shenzhou's stock price fluctuated within a range of 0.34%, with a high of 74.77 yuan and a low of 73.14 yuan, showing a volatile trend [2] - On February 11, 2026, there was a net outflow of 1.1075 million yuan in main funds, while retail investor activity remained high [2] Group 3 - As of February 12, 2026, institutions set a comprehensive target price for Yiqiao Shenzhou at 78.00 yuan, indicating limited upside potential compared to the latest stock price [3] - The forecast for net profit in 2025 is expected to grow by 18.10%, while revenue for 2026 is projected to increase by 9.06% [3] - Market sentiment is neutral, and the frequency of institutional research is relatively low [3]

Core Viewpoint - The "Three-Year Action Plan for Supporting the Transformation and Upgrading of Advanced Manufacturing in Shanghai (2026-2028)" aims to accelerate the establishment of a modern industrial system centered on advanced manufacturing, promoting green and intelligent transformation across various enterprises in Shanghai [1][2]. Group 1: Action Plan Overview - The action plan includes four major actions and 17 measures to enhance the development of advanced manufacturing [1]. - By 2028, Shanghai aims to add 100 manufacturing enterprises with an annual output value exceeding 1 billion yuan and increase the number of large-scale industrial enterprises in the supply chain by 500 [1]. Group 2: Industry Development Paths - The plan outlines three development paths: - For traditional advantageous industries, it emphasizes "optimization and enhancement" [1]. - For leading industries, it promotes "strategic guidance" [1]. - For key and emerging industries, it focuses on "expansion and development" [1]. Group 3: Innovation and Resource Support - The action plan supports enterprises in high-level R&D and high-value product transformation, addressing industry pain points and overcoming key core technologies [2]. - It encourages full-process upgrades, AI integration in manufacturing, and carbon footprint management to achieve quality and efficiency improvements [2]. Group 4: Financial Incentives - The plan provides substantial financial support for R&D, including: - A one-time subsidy of 10 million yuan for enterprises with annual R&D expenditures of 100 million yuan or more [2]. - A one-time subsidy of 5 million yuan for those spending between 50 million and 100 million yuan [2]. - A one-time subsidy of 2 million yuan for R&D expenditures between 1 million and 5 million yuan [2]. Group 5: Additional Financial Support Measures - The plan includes subsidies for fixed asset investment loans related to technology upgrades, with a maximum of 20 million yuan [3]. - Companies upgrading energy-saving processes and equipment can receive rewards based on coal consumption, up to 10 million yuan [3]. - A one-time reward of 200,000 yuan is available for enterprises recognized as national green factories [3].

Market Overview - The Hong Kong stock market opened slightly lower, with the Hang Seng Index down 0.2% at 27,210.56 points, the Hang Seng Tech Index down 0.47% at 5,474.25 points, and the National Enterprises Index down 0.19% at 9,250.27 points [1] - Major tech stocks mostly opened lower, with Alibaba down 1.37%, Tencent down 2.01%, and Meituan down 2.48%, while AI application stocks showed strength, with Zhihui up 8.77% and MINIMAX-WP up 5.65% [1] Company Performance - NetEase reported strong performance, with a net revenue of approximately 112.63 billion yuan, a year-on-year increase of 6.96%, and a net profit of approximately 33.76 billion yuan, up 13.68% [2] - NetEase Cloud Music saw a significant profit increase of 75.4%, with a revenue of 7.76 billion yuan and a profit of 2.75 billion yuan, confirming a turning point in performance [2] Industry Trends - The hard technology and manufacturing sectors showed signs of recovery, with Qiu Tai Technology reporting a 22.8% year-on-year increase in camera module sales and an 18.4% increase in fingerprint recognition module sales, driven by demand in IoT and smart automotive sectors [3] - The renewable energy sector also saw growth, with China Resources Power reporting a 28.4% year-on-year increase in electricity sales, and solar power sales soaring by 72.3% [3] Biopharmaceutical Sector - The biopharmaceutical sector experienced significant positive developments, with Rebio Biotech announcing a global exclusive licensing agreement worth up to 4.4 billion USD, leading to a substantial increase in stock price [4] - Heng Rui Pharmaceutical's product was included in a breakthrough therapy list, with projected global sales exceeding 6.5 billion USD in 2024 [4] Capital Market Activity - Industrial capital is actively engaging in buybacks to stabilize the market, with Geely Automobile repurchasing shares worth approximately 20.30 million HKD and other companies like Kingsoft and Bai Rong Cloud also participating in buybacks [5] - Huili Group is expected to see a profit increase of over 20 times in 2025, indicating a strong performance reversal [5] Institutional Insights - There is a divergence in institutional views regarding market fluctuations, with some suggesting that the recent pullback is a liquidity shock, while others believe that valuation recovery is nearly complete [6] - Specific sectors like AI computing and surgical robots are highlighted for potential growth, with expectations for high performance in 2025 and 2026 [6]

美股巨震收跌，美光闪迪飙升10%引爆存储板块。连续反弹的港股三大指数低开，恒指跌0.2%，国指跌 0.19%，恒生科技指数跌0.47%。大型科技股普遍下跌，美团跌2.4%，百度、腾讯跌2%，正式开源发布 新一代基座模型GLM-5，智谱大涨近9%领衔AI应用股上涨，兆易创新、金山云均走强。另外，生物医 药股、餐饮股、风电股走低。(格隆汇) ...